Resveratrol, an Inhibitor Binding to VEGF, Restores the Pathology of Abnormal Angiogenesis in Retinopathy of Prematurity (ROP) in Mice: Application by Intravitreal and Topical Instillation

Retinopathy of prematurity (ROP) is a severe eye disease leading to blindness. Abnormal vessel formation is the pathological hallmark of neovascular ROP. In forming vessels, vascular endothelial growth factor (VEGF) is an important stimulator. The current anti-ROP therapy has focused on bevacizumab,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Wei-Hui, Zhang, Xiao-Yong, Leung, Ka-Wing, Duan, Ran, Dong, Ting-Xia (Tina), Qin, Qi-Wei, Tsim, Karl Wah-Keung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223486/
https://www.ncbi.nlm.nih.gov/pubmed/35742898
http://dx.doi.org/10.3390/ijms23126455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223486/
https://www.ncbi.nlm.nih.gov/pubmed/35742898
http://dx.doi.org/10.3390/ijms23126455

Ejemplares similares